HNRNPA1 and prostate carcinoma: Notably, HNRNPA1 expression was predictive of disease recurrence in prostate cancer patients with a Gleason score of 7 but not in those with Gleason scores ≤6 or ≥8 (Fig. 4l and Supplementary Fig. 4j), suggesting a prognostic potential of HNRNPA1 in patient stratification.